20.77 USD
+0.34 (+1.66%)
21 USD
+0.23 (+1.11%)
SLP gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. While SLP has a great health rating, its profitability is only average at the moment. SLP is growing strongly while it is still valued neutral. This is a good combination!
1. Profitability
1.1 Basic Checks
- In the past year SLP was profitable.
- In the past year SLP had a positive cash flow from operations.
- Of the past 5 years SLP 4 years were profitable.
- Each year in the past 5 years SLP had a positive operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -46.61%, SLP is doing worse than 68.57% of the companies in the same industry.
- SLP has a Return On Equity (-50.54%) which is comparable to the rest of the industry.
- Looking at the Return On Invested Capital, with a value of 4.45%, SLP is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for SLP is below the industry average of 6.63%.
- The 3 year average ROIC (3.61%) for SLP is below the current ROIC(4.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.61% | ||
| ROE | -50.54% | ||
| ROIC | 4.45% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
1.3 Margins
- SLP's Operating Margin of 9.00% is amongst the best of the industry. SLP outperforms 82.86% of its industry peers.
- In the last couple of years the Operating Margin of SLP has declined.
- SLP's Gross Margin of 59.60% is in line compared to the rest of the industry. SLP outperforms 51.43% of its industry peers.
- In the last couple of years the Gross Margin of SLP has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9% | ||
| PM (TTM) | N/A | ||
| GM | 59.6% |
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SLP is destroying value.
- Compared to 1 year ago, SLP has more shares outstanding
- The number of shares outstanding for SLP has been increased compared to 5 years ago.
- SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- SLP has an Altman-Z score of 23.85. This indicates that SLP is financially healthy and has little risk of bankruptcy at the moment.
- SLP's Altman-Z score of 23.85 is amongst the best of the industry. SLP outperforms 97.14% of its industry peers.
- SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 23.85 |
ROIC/WACC0.46
WACC9.69%
2.3 Liquidity
- A Current Ratio of 5.62 indicates that SLP has no problem at all paying its short term obligations.
- The Current ratio of SLP (5.62) is better than 85.71% of its industry peers.
- A Quick Ratio of 5.62 indicates that SLP has no problem at all paying its short term obligations.
- SLP has a Quick ratio of 5.62. This is amongst the best in the industry. SLP outperforms 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.62 |
3. Growth
3.1 Past
- SLP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 50.00%, which is quite impressive.
- The Earnings Per Share has been growing slightly by 1.07% on average over the past years.
- The Revenue has been growing slightly by 5.69% in the past year.
- The Revenue has been growing by 13.74% on average over the past years. This is quite good.
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
3.2 Future
- SLP is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.12% yearly.
- Based on estimates for the next years, SLP will show a quite strong growth in Revenue. The Revenue will grow by 10.39% on average per year.
EPS Next Y32.34%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- SLP is valuated quite expensively with a Price/Earnings ratio of 34.62.
- SLP's Price/Earnings ratio is a bit cheaper when compared to the industry. SLP is cheaper than 71.43% of the companies in the same industry.
- SLP is valuated rather expensively when we compare the Price/Earnings ratio to 27.32, which is the current average of the S&P500 Index.
- SLP is valuated rather expensively with a Price/Forward Earnings ratio of 21.35.
- SLP's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SLP is cheaper than 77.14% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of SLP to the average of the S&P500 Index (24.32), we can say SLP is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.62 | ||
| Fwd PE | 21.35 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, SLP is valued a bit cheaper than the industry average as 62.86% of the companies are valued more expensively.
- 77.14% of the companies in the same industry are more expensive than SLP, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21 | ||
| EV/EBITDA | 25.77 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.07
PEG (5Y)32.42
EPS Next 2Y29.52%
EPS Next 3Y2.03%
5. Dividend
5.1 Amount
- SLP has a yearly dividend return of 0.61%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.54, SLP pays a better dividend. On top of this SLP pays more dividend than 94.29% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.83, SLP's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
- SLP has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
20.77
+0.34 (+1.66%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)01-08 2026-01-08/amc
Earnings (Next)04-01 2026-04-01
Inst Owners79.38%
Inst Owner Change0.02%
Ins Owners17.2%
Ins Owner Change-0.18%
Market Cap418.31M
Revenue(TTM)78.68M
Net Income(TTM)-64.25M
Analysts80
Price Target24.23 (16.66%)
Short Float %7.04%
Short Ratio3.1
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-18.28%
Min EPS beat(2)-77.15%
Max EPS beat(2)40.59%
EPS beat(4)3
Avg EPS beat(4)71.31%
Min EPS beat(4)-77.15%
Max EPS beat(4)321.12%
EPS beat(8)4
Avg EPS beat(8)23.48%
EPS beat(12)5
Avg EPS beat(12)8.75%
EPS beat(16)7
Avg EPS beat(16)5.82%
Revenue beat(2)2
Avg Revenue beat(2)1.06%
Min Revenue beat(2)0.77%
Max Revenue beat(2)1.36%
Revenue beat(4)4
Avg Revenue beat(4)1.01%
Min Revenue beat(4)0.63%
Max Revenue beat(4)1.36%
Revenue beat(8)6
Avg Revenue beat(8)0.57%
Revenue beat(12)7
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)0.08%
PT rev (1m)3.26%
PT rev (3m)-6.25%
EPS NQ rev (1m)-17.01%
EPS NQ rev (3m)37.85%
EPS NY rev (1m)88.82%
EPS NY rev (3m)82.04%
Revenue NQ rev (1m)1.69%
Revenue NQ rev (3m)-1.55%
Revenue NY rev (1m)0.6%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 34.62 | ||
| Fwd PE | 21.35 | ||
| P/S | 5.32 | ||
| P/FCF | 21 | ||
| P/OCF | 17.7 | ||
| P/B | 3.29 | ||
| P/tB | 7.66 | ||
| EV/EBITDA | 25.77 |
EPS(TTM)0.6
EY2.89%
EPS(NY)0.97
Fwd EY4.68%
FCF(TTM)0.99
FCFY4.76%
OCF(TTM)1.17
OCFY5.65%
SpS3.91
BVpS6.31
TBVpS2.71
PEG (NY)1.07
PEG (5Y)32.42
Graham Number9.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.61% | ||
| ROE | -50.54% | ||
| ROCE | 5.55% | ||
| ROIC | 4.45% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 29.44% | ||
| OM | 9% | ||
| PM (TTM) | N/A | ||
| GM | 59.6% | ||
| FCFM | 25.32% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
ROICexc(3y)6.84%
ROICexc(5y)12.7%
ROICexgc(3y)60.47%
ROICexgc(5y)79.01%
ROCE(3y)4.51%
ROCE(5y)5.69%
ROICexgc growth 3Y-33.77%
ROICexgc growth 5Y-24.05%
ROICexc growth 3Y-37.37%
ROICexc growth 5Y-22.33%
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
F-Score6
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 50.91% | ||
| Cap/Sales | 4.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 164.46% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.62 | ||
| Altman-Z | 23.85 |
F-Score6
WACC9.69%
ROIC/WACC0.46
Cap/Depr(3y)77.49%
Cap/Depr(5y)94.25%
Cap/Sales(3y)6%
Cap/Sales(5y)7.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
EPS Next Y32.34%
EPS Next 2Y29.52%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
EBIT growth 1Y33.64%
EBIT growth 3Y-24.21%
EBIT growth 5Y-10.96%
EBIT Next Year143.92%
EBIT Next 3Y43.31%
EBIT Next 5Y28.01%
FCF growth 1Y53.44%
FCF growth 3Y1.12%
FCF growth 5Y11.57%
OCF growth 1Y36.52%
OCF growth 3Y0.42%
OCF growth 5Y10.69%
SIMULATIONS PLUS INC / SLP FAQ
What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to SLP.
Can you provide the valuation status for SIMULATIONS PLUS INC?
ChartMill assigns a valuation rating of 4 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Fairly Valued.
How profitable is SIMULATIONS PLUS INC (SLP) stock?
SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.
What is the financial health of SIMULATIONS PLUS INC (SLP) stock?
The financial health rating of SIMULATIONS PLUS INC (SLP) is 8 / 10.
Can you provide the expected EPS growth for SLP stock?
The Earnings per Share (EPS) of SIMULATIONS PLUS INC (SLP) is expected to grow by 32.34% in the next year.